6833 — Sinco Pharmaceuticals Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Sinco Pharmaceuticals Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	326	329	438	308	249
Net Total Accounts Receivable
Net Total Receivables	225	390	593	681	644
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	969	1,017	1,433	1,512	1,355
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	256	316	354	371	359
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,233	1,424	1,891	2,000	1,847
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	726	791	1,232	1,332	1,151
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	858	821	1,263	1,338	1,153
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	375	604	628	663	694
Total Liabilities & Shareholders' Equity	1,233	1,424	1,891	2,000	1,847
Total Common Shares Outstanding